UK markets open in 2 hours 3 minutes

Champions Oncology, Inc. (CSBR)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
4.8600-0.1400 (-2.80%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/04/2023
30/04/2022
30/04/2021
Total revenue
54,096
53,870
49,109
41,040
Cost of revenue
27,122
29,532
23,632
21,446
Gross profit
26,974
24,338
25,477
19,594
Operating expenses
Research development
10,262
11,545
9,374
7,196
Selling general and administrative
16,470
17,242
15,496
12,032
Total operating expenses
26,732
28,787
24,870
19,228
Operating income or loss
242
-4,449
607
366
Total other income/expenses net
-94
-818
-24
71
Income before tax
148
-5,267
583
437
Income tax expense
40
68
35
75
Income from continuing operations
108
-5,335
548
362
Net income
108
-5,335
548
362
Net income available to common shareholders
108
-5,335
548
362
Basic EPS
-0.71
-0.39
0.04
0.03
Diluted EPS
-0.71
-0.39
0.04
0.02
Basic average shares
13,546
13,542
13,197
13,139
Diluted average shares
13,546
13,542
14,160
14,574